BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 10775638)

  • 1. Distinct mechanisms of entry by envelope glycoproteins of Marburg and Ebola (Zaire) viruses.
    Chan SY; Speck RF; Ma MC; Goldsmith MA
    J Virol; 2000 May; 74(10):4933-7. PubMed ID: 10775638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folate receptor-alpha is a cofactor for cellular entry by Marburg and Ebola viruses.
    Chan SY; Empig CJ; Welte FJ; Speck RF; Schmaljohn A; Kreisberg JF; Goldsmith MA
    Cell; 2001 Jul; 106(1):117-26. PubMed ID: 11461707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential induction of cellular detachment by envelope glycoproteins of Marburg and Ebola (Zaire) viruses.
    Chan SY; Ma MC; Goldsmith MA
    J Gen Virol; 2000 Sep; 81(Pt 9):2155-2159. PubMed ID: 10950971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics of Filoviridae: Marburg and Ebola viruses.
    Beer B; Kurth R; Bukreyev A
    Naturwissenschaften; 1999 Jan; 86(1):8-17. PubMed ID: 10024977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Filoviruses: recent advances and future challenges.
    Bray M; Pilch R
    Expert Rev Anti Infect Ther; 2006 Dec; 4(6):917-21. PubMed ID: 17181407
    [No Abstract]   [Full Text] [Related]  

  • 6. The glycoproteins of Marburg and Ebola virus and their potential roles in pathogenesis.
    Feldmann H; Volchkov VE; Volchkova VA; Klenk HD
    Arch Virol Suppl; 1999; 15():159-69. PubMed ID: 10470276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging diseases. On the trail of Ebola and Marburg viruses.
    Balter M
    Science; 2000 Nov; 290(5493):923-5. PubMed ID: 11184732
    [No Abstract]   [Full Text] [Related]  

  • 8. Filoviruses require endosomal cysteine proteases for entry but exhibit distinct protease preferences.
    Misasi J; Chandran K; Yang JY; Considine B; Filone CM; Côté M; Sullivan N; Fabozzi G; Hensley L; Cunningham J
    J Virol; 2012 Mar; 86(6):3284-92. PubMed ID: 22238307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mannose-binding lectin binds to Ebola and Marburg envelope glycoproteins, resulting in blocking of virus interaction with DC-SIGN and complement-mediated virus neutralization.
    Ji X; Olinger GG; Aris S; Chen Y; Gewurz H; Spear GT
    J Gen Virol; 2005 Sep; 86(Pt 9):2535-2542. PubMed ID: 16099912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue and cellular tropism, pathology and pathogenesis of Ebola and Marburg viruses.
    Martines RB; Ng DL; Greer PW; Rollin PE; Zaki SR
    J Pathol; 2015 Jan; 235(2):153-74. PubMed ID: 25297522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of treatment strategies to combat Ebola and Marburg viruses.
    Paragas J; Geisbert TW
    Expert Rev Anti Infect Ther; 2006 Feb; 4(1):67-76. PubMed ID: 16441210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of Ebola and Marburg Virus Entry by G Protein-Coupled Receptor Antagonists.
    Cheng H; Lear-Rooney CM; Johansen L; Varhegyi E; Chen ZW; Olinger GG; Rong L
    J Virol; 2015 Oct; 89(19):9932-8. PubMed ID: 26202243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physicochemical properties of Marburg virus: evidence for three distinct virus strains and their relationship to Ebola virus.
    Kiley MP; Cox NJ; Elliott LH; Sanchez A; DeFries R; Buchmeier MJ; Richman DD; McCormick JB
    J Gen Virol; 1988 Aug; 69 ( Pt 8)():1957-67. PubMed ID: 3404120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of viral envelope GP2 in Ebola virus entry into cells expressing the macrophage galactose-type C-type lectin.
    Usami K; Matsuno K; Igarashi M; Denda-Nagai K; Takada A; Irimura T
    Biochem Biophys Res Commun; 2011 Apr; 407(1):74-8. PubMed ID: 21362405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Ebola and Marburg viruses: the humans strike back].
    Alazard-Dany N; Ottmann Terrangle M; Volchkov V
    Med Sci (Paris); 2006 Apr; 22(4):405-10. PubMed ID: 16597410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ebola and Marburg viruses: pathogenesis and development of countermeasures.
    Hensley LE; Jones SM; Feldmann H; Jahrling PB; Geisbert TW
    Curr Mol Med; 2005 Dec; 5(8):761-72. PubMed ID: 16375711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Ebola virus and Marburg virus].
    Morikawa S
    Nihon Rinsho; 2003 Mar; 61 Suppl 3():544-9. PubMed ID: 12718026
    [No Abstract]   [Full Text] [Related]  

  • 18. Enzyme-linked immunosorbent assays for detection of antibodies to Ebola and Marburg viruses using recombinant nucleoproteins.
    Saijo M; Niikura M; Morikawa S; Ksiazek TG; Meyer RF; Peters CJ; Kurane I
    J Clin Microbiol; 2001 Jan; 39(1):1-7. PubMed ID: 11136739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Viral hemorrhagic fevers--Ebola hemorrhagic fever, Marburg virus disease, and Lassa fever].
    Taniguchi K
    Nihon Naika Gakkai Zasshi; 2004 Nov; 93(11):2303-8. PubMed ID: 15624463
    [No Abstract]   [Full Text] [Related]  

  • 20. Experimental Inoculation of Egyptian Rousette Bats (Rousettus aegyptiacus) with Viruses of the Ebolavirus and Marburgvirus Genera.
    Jones ME; Schuh AJ; Amman BR; Sealy TK; Zaki SR; Nichol ST; Towner JS
    Viruses; 2015 Jun; 7(7):3420-42. PubMed ID: 26120867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.